Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile dysfunction].

L Rodríquez Vela1, A Gonzalvo Ibarra, D Pascual Regueiro

  • 1Unidad de Andrología, Servicio de Urología, Hospital Universitario Miguel Servet, Zaragoza.

Actas Urologicas Espanolas
|January 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One of the greatest; the death of Francesc Xavier Solé Balcells (1924-2014).

Actas urologicas espanolas·2014
Same author

[Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms].

Archivos espanoles de urologia·2012
Same author

[A new case of malignant fibrous histiocytoma arising from the renal capsule].

Actas urologicas espanolas·2010
Same author

[Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors].

Actas urologicas espanolas·2008
Same author

[Are there any differences between the characteristics and the behavior of bladder cancer according to the age of presentation? Our experience].

Actas urologicas espanolas·2007
Same author

[Usefulness of renal resistive index in the diagnosis and evolution of the obstructive uropathy. Experimental study].

Actas urologicas espanolas·2007
Same journal

Comparative outcomes of Mini-PCNL and suction-assisted flexible ureteroscopy in patients with renal stones ≥2 cm.

Actas urologicas espanolas·2026
Same journal

Morphometric changes in pelvic floor structure following non-invasive rehabilitation and neuromodulation assessed by ultrasound imaging.

Actas urologicas espanolas·2026
Same journal

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same journal

i-PCNL: a novel ureteral-catheter application for continuous unidirectional high-flow irrigation during Percutaneous Nephrolithotomy. Technique description and preliminary outcomes.

Actas urologicas espanolas·2026
Same journal

Reconstructing the reconstructed: Outcomes of redo-urethroplasty for recurrent urethral strictures.

Actas urologicas espanolas·2026
Same journal

Functional outcomes of pyeloplasty in children with reduced preoperative renal function: A multicenter study.

Actas urologicas espanolas·2026
See all related articles

Erectile dysfunction (ED) affects 19% of Spanish men aged 25-70. This review details ED pathophysiology, diagnosis, and treatments, including oral medications and future therapies, emphasizing individualized patient care.

Area of Science:

  • Urology
  • Andrology
  • Pharmacology

Context:

  • Erectile dysfunction (ED) impacts a significant portion of the male population in Spain, with approximately 19% of men aged 25-70 affected.
  • The prevalence suggests a substantial need for accessible and effective medical attention for this condition.

Purpose:

  • To provide an updated review of erectile dysfunction (ED), covering its pathophysiology, diagnostic approaches, and current and emerging treatment strategies.
  • To detail oral pharmacotherapies, including established drugs and novel agents in premarketing phases, and discuss alternative treatments like intracavernous injections and surgical options.

Summary:

  • Individualized patient assessment, including clinical history, physical examination, and laboratory testing, is crucial for managing ED.
  • Treatment should address underlying conditions such as diabetes and arteriosclerosis, and correct modifiable risk factors.

Related Experiment Videos

  • First-line treatments involve oral medications (sildenafil, apomorphine), with newer PDE5 inhibitors offering improved selectivity. Testosterone replacement is indicated only for confirmed hypogonadism.
  • Second-line options include intracavernous injections (Prostaglandin E1) and, for select cases, penile prostheses or revascularization. Psychotherapy is an adjunct for psychogenic ED.

    • Impact:

    • This comprehensive overview aims to guide healthcare professionals in the optimal diagnosis and management of erectile dysfunction.
    • Highlights emerging pharmacological advancements and established therapeutic modalities to improve patient outcomes and quality of life.